These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34693105)

  • 1. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangaswamy R; Jeyaraman J
    ACS Omega; 2021 Oct; 6(41):26829-26845. PubMed ID: 34693105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
    Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
    Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
    J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Desulfated Saponin from
    Shahinozzaman M; Ishii T; Takano R; Halim MA; Hossain MA; Tawata S
    Sci Pharm; 2018 Aug; 86(3):. PubMed ID: 30200330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of WaterMap-guided structure-based virtual screening in novel drug discovery.
    Kaczor AA; Zięba A; Matosiuk D
    Expert Opin Drug Discov; 2024; 19(1):73-83. PubMed ID: 37807912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Pak1 inhibitors using water thermodynamic analysis.
    Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
    J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4.
    Wakchaure P; Velayutham R; Roy KK
    J Biomol Struct Dyn; 2019 Aug; 37(12):3048-3057. PubMed ID: 30079805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
    Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
    J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and simulation studies on SARS-CoV-2 M
    Lokhande KB; Doiphode S; Vyas R; Swamy KV
    J Biomol Struct Dyn; 2021 Nov; 39(18):7294-7305. PubMed ID: 32815481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer.
    El-Baba C; Mahadevan V; Fahlbusch FB; Mohan S S; Rau TT; Gali-Muhtasib H; Schneider-Stock R
    Mol Cancer; 2014 Aug; 13():201. PubMed ID: 25174975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
    Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
    J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ibrahim MAA; Abdelrahman AHM; Hegazy MF
    J Biomol Struct Dyn; 2021 Sep; 39(15):5756-5767. PubMed ID: 32684114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target.
    Ikram S; Ahmad J; Durdagi S
    J Mol Graph Model; 2020 Mar; 95():107462. PubMed ID: 31786094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
    Han D; Wang H; Cui W; Zhang B; Chen BZ
    Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding mechanism of spinosine and venenatine molecules with p300 HAT enzyme: Molecular screening, molecular dynamics and free-energy analysis.
    Magudeeswaran S; Poomani K
    J Cell Biochem; 2020 Feb; 121(2):1759-1777. PubMed ID: 31633226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.